NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390 | +10.2% | 3,826 | +9.1% | 0.03% | +9.7% |
| Q2 2023 | $354 | -14.1% | 3,507 | -21.7% | 0.03% | -6.1% |
| Q1 2023 | $412 | +45.1% | 4,481 | +43.3% | 0.03% | +22.2% |
| Q4 2022 | $284 | -99.9% | 3,126 | -21.9% | 0.03% | -10.0% |
| Q3 2022 | $304,000 | +35.7% | 4,004 | +50.8% | 0.03% | +36.4% |
| Q2 2022 | $224,000 | -73.7% | 2,655 | -72.8% | 0.02% | -82.5% |
| Q2 2020 | $853,000 | +5.8% | 9,769 | -0.0% | 0.13% | -21.7% |
| Q1 2020 | $806,000 | -32.4% | 9,771 | -22.4% | 0.16% | -3.6% |
| Q4 2019 | $1,193,000 | +93.4% | 12,594 | +77.4% | 0.17% | +72.2% |
| Q3 2019 | $617,000 | +325.5% | 7,098 | +348.1% | 0.10% | +321.7% |
| Q2 2019 | $145,000 | -89.8% | 1,584 | +1064.7% | 0.02% | +187.5% |
| Q1 2019 | $1,418,000 | +70800.0% | 136 | +1.5% | 0.01% | -42.9% |
| Q4 2018 | $2,000 | -98.1% | 134 | +13300.0% | 0.01% | -30.0% |
| Q3 2018 | $108,000 | -54.4% | 1 | -100.0% | 0.02% | -39.4% |
| Q2 2018 | $237,000 | – | 3,134 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |